These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25800176)

  • 21. Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma.
    Mori S; Aoki T; Sakuraoka Y; Shimizu T; Yamaguchi T; Park KH; Matsumoto T; Shiraki T; Iso Y; Kubota K
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):109-120. PubMed ID: 33825991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
    Bouvet M; Hoffman RM
    Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence-guided surgery of prostate cancer bone metastasis.
    Miwa S; Matsumoto Y; Hiroshima Y; Yano S; Uehara F; Yamamoto M; Zhang Y; Kimura H; Hayashi K; Yamamoto N; Bouvet M; Sugimoto N; Tsuchiya H; Hoffman RM
    J Surg Res; 2014 Nov; 192(1):124-33. PubMed ID: 24972740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superiority of extended neoadjuvant chemotherapy with gemcitabine in pancreatic cancer: a comparative analysis in a clinically adapted orthotopic xenotransplantation model in SCID beige mice.
    Egberts JH; Schniewind B; Sipos B; Hinz S; Kalthoff H; Tepel J
    Cancer Biol Ther; 2007 Aug; 6(8):1227-32. PubMed ID: 17700058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence-guided surgery of retroperitoneal-implanted human fibrosarcoma in nude mice delays or eliminates tumor recurrence and increases survival compared to bright-light surgery.
    Uehara F; Hiroshima Y; Miwa S; Tome Y; Yano S; Yamamoto M; Matsumoto Y; Maehara H; Tanaka K; Bouvet M; Kanaya F; Hoffman RM
    PLoS One; 2015; 10(2):e0116865. PubMed ID: 25710463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved disease-free survival and overall survival after fluorescence-guided surgery of liver metastasis in an orthotopic nude mouse model.
    Murakami T; Hiroshima Y; Zhang Y; Bouvet M; Chishima T; Tanaka K; Endo I; Hoffman RM
    J Surg Oncol; 2015 Aug; 112(2):119-24. PubMed ID: 26266663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.
    Kawaguchi K; Igarashi K; Miyake K; Lwin TM; Miyake M; Kiyuna T; Hwang HK; Murakami T; Delong JC; Singh SR; Clary B; Bouvet M; Unno M; Hoffman RM
    Tissue Cell; 2018 Jun; 52():124-128. PubMed ID: 29857821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
    J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Yang H; Tong Z; Shen L; Sun YU; Hoffman RM; Huang J
    Anticancer Res; 2020 Sep; 40(9):4969-4978. PubMed ID: 32878785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy.
    Takano S; Togawa A; Yoshitomi H; Shida T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Tomonaga T; Nomura F; Miyazaki M
    Ann Surg Oncol; 2008 Nov; 15(11):3157-68. PubMed ID: 18712570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model.
    Miyake K; Higuchi T; Oshiro H; Zhang Z; Sugisawa N; Park JH; Razmjooei S; Katsuya Y; Barangi M; Li Y; Nelson SD; Murakami T; Homma Y; Hiroshima Y; Matsuyama R; Bouvet M; Chawla SP; Singh SR; Endo I; Hoffman RM
    Biomed Pharmacother; 2019 Sep; 117():109093. PubMed ID: 31200257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful resection of advanced pancreatic tail cancer after neoadjuvant gemcitabine chemotherapy: report of a case.
    Matsuda T; Taniguchi F; Minato H; Nomura H; Tsuda T; Aikawa I
    Surg Today; 2006; 36(8):754-7. PubMed ID: 16865525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model.
    Miyake K; Kiyuna T; Miyake M; Kawaguchi K; Zhang Z; Wangsiricharoen S; Razmjooei S; Oshiro H; Higuchi T; Li Y; Nelson SD; Murakami T; Hiroshima Y; Kumamoto T; Matsuyama R; Bouvet M; Singh SR; Chawla SP; Endo I; Hoffman RM
    Biochem Biophys Res Commun; 2019 Feb; 509(4):1041-1046. PubMed ID: 30660363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
    Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.
    Metildi CA; Kaushal S; Snyder CS; Hoffman RM; Bouvet M
    J Surg Res; 2013 Jan; 179(1):87-93. PubMed ID: 23079571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.
    Motoi F; Satoi S; Honda G; Wada K; Shinchi H; Matsumoto I; Sho M; Tsuchida A; Unno M;
    J Gastroenterol; 2019 Feb; 54(2):194-203. PubMed ID: 30182219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer.
    Kawaguchi K; Miyake K; Han Q; Li S; Tan Y; Igarashi K; Kiyuna T; Miyake M; Higuchi T; Oshiro H; Zhang Z; Razmjooei S; Wangsiricharoen S; Bouvet M; Singh SR; Unno M; Hoffman RM
    Cancer Lett; 2018 Sep; 432():251-259. PubMed ID: 29928962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model.
    Lee NC; Bouvet M; Nardin S; Jiang P; Baranov E; Rashidi B; Yang M; Wang X; Moossa AR; Hoffma RM
    Clin Exp Metastasis; 2000; 18(5):379-84. PubMed ID: 11467769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
    Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
    BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence-guided surgery improves outcome in an orthotopic osteosarcoma nude-mouse model.
    Miwa S; Hiroshima Y; Yano S; Zhang Y; Matsumoto Y; Uehara F; Yamamoto M; Kimura H; Hayashi K; Bouvet M; Tsuchiya H; Hoffman RM
    J Orthop Res; 2014 Dec; 32(12):1596-601. PubMed ID: 25138581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.